Enveda secures $311M to bring more nature-derived AI drugs into clinical trials
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
$17. 2 million investment, spanning three to five years from Simons Foundation International , XTX Markets , and Siegel Family Endowment #Philanthropy) https://blog.
Funding rounds indicate market confidence and shape which platforms will have resources for long-term development. Tracking these signals helps teams evaluate vendor stability and ecosystem health.
The round valued the AI biotech at $2 billion. It is currently testing drugs that treat skin conditions and preserve weight loss after stopping GLP-1s.
StrictlyVC joins TechCrunch Disrupt 2026 to discuss the changing VC landscape thanks to AI. Get your Investor Pass to join these exclusive sessions.
Ema has raised $140 million to date and has more than 50 enterprise customers, including Google and Microsoft.